A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Sweden, as Part of Local Clinical Practice
NCT04601753
·
clinicaltrials.gov ↗
COMPLETED
Status
194
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG:
Oral Semaglutide
Sponsor
Novo Nordisk A/S